`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX, INC.
`
`Petitioner,
`
`V.
`
`UCB BIOPHARMA S.A.
`
`Patent Owner.
`
`US. Patent No. 8,633,194 to Fanara et al.
`
`Issue Date: January 21, 2014
`Title: Pharmaceutical composition of piperazine derivatives
`
`Inter Partes Review No.: IPR2019-00400
`
`PETITIONER’S POWER OF ATTORNEY
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`US. Patent and Trademark Office
`
`PO. Box 1450
`
`Alexandria, VA 223 13-1450
`
`
`
`PETITIONER’S POWER OF ATTORNEY
`
`Pursuant to 37 CPR. § 42.10(b), Petitioner Apotex Inc., having a principal
`
`place of business at 150 Signet Drive, Toronto, Ontario M9L 1T9, Canada, hereby
`
`appoints the following practitioners as its attorneys to transact all business in the
`
`United States Patent & Trademark Office Association with any inter partes review
`
`of US. Patent No 8,633,194:
`
`
`
`
`
`Back-up Counsel
`
`Alissa M. Pacchioli
`
`Reg. No. 74,252
`Katten Muchin Rosenman LLP
`
`
`
`
`
`
`
`
`550 S. Tryon Street, Suite 2900
`
`
`Charlotte, NC 28202—4213
`
`
`
`alissa.pacchioli@kattenlaw.com
`
`
` Joseph M. Janusz
`
`Reg. No. 70,396;
`
`Katten Muchin Rosenman LLP
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`
`joe.j anusz @kattenlaw.com
`
`
`
`
`
`Lead Counsel
`
`Jitendra Malik, Ph.D.
`
`Reg. No. 55,823
`Katten Muchin Rosenman
`
`LLP
`
`550 S. Tryon Street, Suite
`2900
`
`Charlotte, NC 28202-4213
`jitty.malik@kattenlaw.com
`
`
`
`
`
`
`
`
`Lance Soderstrom
`
`Reg. No. 65,405
`Katten Muchin Rosenman LLP
`
`575 Madison Avenue
`
`New York, NY 10022-2585
`
`lance.soderstrom@kattenlaw.com
`
`and all practitioners associated with Customer Number 27160.
`
`
`
`I have the authority to execute this document on behalf of Apotex Inc.
`
`W/
`Name: 0186? Kai! 114.174
`Title: Senior P6146!“ C‘Oufife/
`Date: December L, 2018
`
`